Sling Therapeutics
MI - Ann ArborBiotechnology
Focus: Sling Therapeutics is a pre-revenue biotechnology company focused on oral small molecule therapeutics for thyroid eye disease, spanning ophthalmology and endocrinology. The company is based in Ann Arbor, Michigan and remains in clinical development stage.
Profile data last refreshed 23h ago · AI intelligence enriched 1w ago
Open Jobs
0
About Sling Therapeutics
AI assessmentNot HiringNo open roles listed right now. Follow Sling Therapeutics to get notified when they start hiring — the background below is worth knowing for when they do.
Generated by Claude from Sling Therapeutics's SEC filings, pipeline programs, hiring velocity, FDA actions, and WARN data. Inference, not editorial — verify before quoting.
Data completeness
1/9 — Limited
Company HealthSolid
Pipeline
Early-stage
2 total
LOE Risk
Protected
No near-term cliffs
Hiring
0 open
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Pipeline & Clinical Trials
linsitinib
Thyroid Eye DiseaseClinical Trials (2)
NCT07753603Study to Assess Linsitinib in Participants With Moderate to Severe Active Thyroid Eye Disease (TED)
Phase 3Help build intelligence for Sling Therapeutics
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.